Product Images Ebanga

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Ebanga NDC 80673-777 by Ridgeback Biotherapeutics, Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - ebanga 01

Figure 1 - ebanga 01

Image - ebanga 02

Image - ebanga 02

Not available.*

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 80673-777-01 - ebanga 03

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 80673-777-01 - ebanga 03

This is a product description for Ebanga, a medication used intravenously. The medication comes in the form of lyophilized imabs. Each vial contains 400mg without preservatives and should be further diluted. The medication does not meet the US Standard of Potency. The code "NDC 8067377701 Rxonly" is present. The text also mentions a website where more information is available.*

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 80673-777-04 - ebanga 04

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 80673-777-04 - ebanga 04

This is a description of a medication called Ebanga (ansuvimab-zykl) that comes in a vial containing 400 mg of the medication to be mixed with other medications for injection to be administered intravenously. The medication comes without preservative, and there is no specified standard for patency. It is monitored, and lot number o000 can be seen on the package. Its NDC number is 80673-777-04, and it can be accessed through ebanga.com. Four boxes containing 36 vials each of 400 mg are included in the package.*

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 80673-777-08 - ebanga 05

PRINCIPAL DISPLAY PANEL - Kit Carton - NDC 80673-777-08 - ebanga 05

This is a description of a drug called Ebanga which is used for intravenous use. It comes in powder form in a vial containing 400mg of the drug. It requires further dilution before injection. Each package contains 8 boxes with 36 vials each. The text also includes the drug's National Drug Code (NDC) and website for more information.*

PRINCIPAL DISPLAY PANEL - 400 mg Vial Label - ebanga 06

PRINCIPAL DISPLAY PANEL - 400 mg Vial Label - ebanga 06

NDC 80673-001-01 Rx only Ebanga (ansuvimab-glykl) is an injectable medication available in 400mg vials for intravenous use. The medication needs to be reconstituted and diluted before administration, and recommended dosage should be referred to in the prescribing information. Any unused portion of the medication from a single-use vial should be discarded. The medication should be stored at 2°C to 8°C (36°F to 46°F), protected from light, and not frozen or shaken. The manufacturer is Ridgeback Blotherapeutics, LP, located in Miami, FL, and the website is wwwebanga.com.*

PRINCIPAL DISPLAY PANEL - 400 mg Vial Carton - ebanga 07

PRINCIPAL DISPLAY PANEL - 400 mg Vial Carton - ebanga 07

This is a description of Ansuvimab-zykl, a 400mg powder that requires reconstitution for intravenous use. The package contains 36 vials without preservatives, and the standard of potency is not specified. The NDC 2067300136 number is mentioned along with lot information. The dosage is subject to prescribing information. Instructions are given on the website ebanga.com, and its contact details are also available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.